Microbial Genomics
Microorganisms were the important living things on Earth and went before the animals and plants by in excess of 3 billion years. They are the foundation of the biosphere, from both a transformative and a natural perspective. It has been assessed that microbial species incorporate around 60% of the Earth's biomass. The genetic, metabolic and physiological arranged assortment of microbial species is unmistakably more conspicuous than that found in plants and animals. In any case, the ok assortment of the microbial world is, as it were, dark, with shy of what one-bit off 1% of the assessed 2–3 billion microbial species perceived. Of those species that have been depicted, their natural arranged assortment is incredible, having changed in accordance with create under boundaries of temperature, pH, salt concentration and oxygen levels.
Possibly no other region of research has been so strengthened by the utilization of genomic development than the microbial field. It was only five years back that The Institute for Genomic Research (TIGR) circulated the essential completion genome course of action for a free-living structure, Haemophilus influenzae2; since that at first report another 27 microbial genome progressions have been conveyed, with no under 10–20 distinct endeavors at or close climax. These development addresses, overall, one completed genome gathering at customary interims and all signs are that this pace will continue quickening.
Related Conference of Microbial Genomics
19th World Congress on Advances in Stem Cell Research and Regenerative Medicine
19th International Conference on Human Genomics and Genomic Medicine
Microbial Genomics Conference Speakers
Recommended Sessions
- Animal Genetics
- Bioinformatics and Computational Biology
- Biomarkers and Microarrays
- Cancer Genomics
- Clinical genomics
- Comparative Genomics
- Epigenomics and Epigenetics
- Functional Genomics
- Gene Editing and Genetic Engineering
- Genetic Disorder
- Genomic Instability
- Genomic Medicine
- Microbial Genomics
- Microbiome functioning
- Next generation sequencing
- Nutrigenomics
- Personalized and Regenerative Medicine
- Pharmacogenomics
- Plant Genomics and Molecular Pharming
- Structural Genomics
- Trends in Genomics and Pharmacogenomics
Related Journals
Are you interested in
- Adult Stem Cells and Tissue-Specific Regeneration - Regenerative Medicine_2026 (France)
- Advanced Gene Therapeutics - Cell Signaling 2026 (France)
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (Japan)
- Bioengineering Therapeutics - Cell Signaling 2026 (France)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (Japan)
- Cancer Stem Cells and Oncology - Stemgen 2026 (Japan)
- Cardiovascular Regeneration - Stemgen 2026 (Japan)
- Cardiovascular Regeneration and Stem Cell Therapeutics - Regenerative Medicine_2026 (France)
- Cell Biology - Cell Signaling 2026 (France)
- Cell Culture and Bioprocessing - Cell Signaling 2026 (France)
- Cell Cycle/Proliferation - Cell Signaling 2026 (France)
- Cell Death and Viability - Cell Signaling 2026 (France)
- Cell Science and Stem Cell Research - Cell Signaling 2026 (France)
- Cellular Signaling - Cell Signaling 2026 (France)
- Cellular Therapies - Cell Signaling 2026 (France)
- Clinical Trials and Research in Stem Cell in Cancer Therapy - Cell Signaling 2026 (France)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (Japan)
- Embryonic Stem Cells and Pluripotent Stem Cells - Regenerative Medicine_2026 (France)
- Epidermis Stem Cell & Cancer Epidemiology - Cell Signaling 2026 (France)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (Japan)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (Japan)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (Japan)
- Hematopoietic Stem Cell Transplantation - Regenerative Medicine_2026 (France)
- Human Gene Therapy - Cell Signaling 2026 (France)
- Immunotherapy - Cell Signaling 2026 (France)
- Induced Pluripotent Stem Cells (iPSCs) - Regenerative Medicine_2026 (France)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (Japan)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (Japan)
- Mesenchymal Stem Cells: Biology and Therapeutic Applications - Regenerative Medicine_2026 (France)
- Molecular Epigenetics - Cell Signaling 2026 (France)
- Nano-Therapy - Cell Signaling 2026 (France)
- Nanotechnology in Stem Cell - Cell Signaling 2026 (France)
- Orthopedic Regenerative Medicine and Bone Tissue Engineering - Regenerative Medicine_2026 (France)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (Japan)
- Regenerative Medicine - Cell Signaling 2026 (France)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (Japan)
- Regenerative Medicine: Current Advances and Future Perspectives - Regenerative Medicine_2026 (France)
- Regulatory and Ethical Issues of Therapies. - Cell Signaling 2026 (France)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (Japan)
- Stem Cell Biology and Cellular Mechanisms - Regenerative Medicine_2026 (France)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (Japan)
- Stem Cell in Drug Development - Cell Signaling 2026 (France)
- Stem Cell Therapies - Cell Signaling 2026 (France)
- Stem Cell Therapy for Neurological Disorders - Regenerative Medicine_2026 (France)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (Japan)

